- Home
- MYGN vs DNUT Comparison
MYGN vs DNUT Comparison
Compare MYGN & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- DNUT
- Stock Information
- Founded
- MYGN 1991
- DNUT 1937
- Country
- MYGN United States
- DNUT United States
- Employees
- MYGN N/A
- DNUT N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- DNUT Food Chains
- Sector
- MYGN Health Care
- DNUT Consumer Staples
- Exchange
- MYGN Nasdaq
- DNUT Nasdaq
- Market Cap
- MYGN 744.7M
- DNUT 505.6M
- IPO Year
- MYGN 1995
- DNUT 2021
- Fundamental
- Price
- MYGN $5.63
- DNUT $3.44
- Analyst Decision
- MYGN Hold
- DNUT Buy
- Analyst Count
- MYGN 15
- DNUT 8
- Target Price
- MYGN $15.14
- DNUT $10.23
- AVG Volume (30 Days)
- MYGN 1.7M
- DNUT 3.8M
- Earning Date
- MYGN 08-05-2025
- DNUT 08-07-2025
- Dividend Yield
- MYGN N/A
- DNUT 4.07%
- EPS Growth
- MYGN N/A
- DNUT N/A
- EPS
- MYGN N/A
- DNUT N/A
- Revenue
- MYGN $831,300,000.00
- DNUT $1,597,883,000.00
- Revenue This Year
- MYGN N/A
- DNUT N/A
- Revenue Next Year
- MYGN $6.68
- DNUT $2.80
- P/E Ratio
- MYGN N/A
- DNUT N/A
- Revenue Growth
- MYGN 7.38
- DNUT N/A
- 52 Week Low
- MYGN $3.81
- DNUT $2.50
- 52 Week High
- MYGN $29.30
- DNUT $12.68
- Technical
- Relative Strength Index (RSI)
- MYGN 60.69
- DNUT 66.12
- Support Level
- MYGN $4.90
- DNUT $2.50
- Resistance Level
- MYGN $5.74
- DNUT $2.72
- Average True Range (ATR)
- MYGN 0.27
- DNUT 0.17
- MACD
- MYGN 0.11
- DNUT 0.11
- Stochastic Oscillator
- MYGN 88.78
- DNUT 98.95
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About DNUT Krispy Kreme Inc.
Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.